Nexalin Technology (NXL) Enterprise Value (2021 - 2026)

Nexalin Technology's Enterprise Value history runs 6 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 32.05% year-over-year to -$2.7 million in Q1 2026; TTM through Mar 2026 was -$2.7 million, a 32.05% decrease from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 76.35% from the prior year.
• Enterprise Value rose to -$2.7 million in Q1 2026 per NXL's latest filing, from -$6.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$848796.0 in Q2 2024 and bottomed at -$10.6 million in Q1 2023.
• The 5-year median for Enterprise Value is -$5.8 million (2025), against an average of -$5.5 million.
• Across the five-year window, Enterprise Value plunged 956.84% in 2022 and surged 90.49% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$7.0 million in 2022, then soared by 57.84% to -$2.9 million in 2023, then slipped by 18.03% to -$3.5 million in 2024, then slumped by 76.35% to -$6.1 million in 2025, then jumped by 55.87% to -$2.7 million in 2026.
• Per Business Quant, the three latest NXL Enterprise Value figures stand at -$2.7 million (Q1 2026), -$6.1 million (Q4 2025), and -$4.4 million (Q3 2025).